Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations
Status:
Completed
Trial end date:
2017-12-11
Target enrollment:
Participant gender:
Summary
This study will test if local therapies in addition to erlotinib can improve responses and
delay the time until new treatment is required. This study will also collect blood samples
for research blood tests.